Cargando…
Advances in Biomarker-Driven Targeted Therapies in Thyroid Cancer
SIMPLE SUMMARY: This article reviews current treatment practices for thyroid cancer with a focus on novel targeted molecular therapy. Rapidly expanding knowledge of the molecular biology of these cancers coupled with the increased availability of genetic testing has led to exciting paradigm shifts i...
Autores principales: | Mishra, Prachi, Laha, Dipranjan, Grant, Robert, Nilubol, Naris |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699087/ https://www.ncbi.nlm.nih.gov/pubmed/34944814 http://dx.doi.org/10.3390/cancers13246194 |
Ejemplares similares
-
The Role of Tumor Necrosis Factor in Manipulating the Immunological Response of Tumor Microenvironment
por: Laha, Dipranjan, et al.
Publicado: (2021) -
New Therapies for Advanced Thyroid Cancer
por: Laha, Diprajan, et al.
Publicado: (2020) -
Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
por: Laha, Dipranjan, et al.
Publicado: (2022) -
Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome
por: Boufraqech, Myriem, et al.
Publicado: (2019) -
Current Status and Future Targeted Therapy in Adrenocortical Cancer
por: Alyateem, George, et al.
Publicado: (2021)